Key result
Activation of acetylcholine receptors through electrical and pharmacological interventions is associated with cardioprotective effects against myocardial ischemia/reperfusion injury.
Why the study?
Does acetylcholine receptor activation improve cardioprotection against myocardial ischemia/reperfusion injury in experimental models?
Does acetylcholine receptor activation improve cardioprotection against myocardial ischemia/reperfusion injury in experimental models?
Activation of acetylcholine receptors represents a potential therapeutic strategy for mitigating myocardial ischemia/reperfusion injury during acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
Acetylcholine receptor activation should not yet alter clinical practice in ischemia/reperfusion injury; leaves open its therapeutic potential pending randomized human trials.
Acute myocardial infarction (AMI) is the most common cause of acute myocardial injury and its most clinically significant form. The most effective treatment for AMI is to restore an adequate coronary blood flow to the ischemic myocardium as quickly as possible. However, reperfusion of an ischemic region can induce cardiomyocyte death, a phenomenon termed "myocardial ischemia/reperfusion (I/R) injury". Disruption of cardiac parasympathetic (vagal) activity is a common hallmark of a variety of cardiovascular diseases including AMI. Experimental studies have shown that increased vagal activity exerts cardioprotective effects against myocardial I/R injury. In addition, acetylcholine (ACh), the principle cardiac vagal neurotransmitter, has been shown to replicate the cardioprotective effects of cardiac ischemic conditioning. Moreover, studies have shown that cardiomyocytes can synthesize and secrete ACh, which gives further evidence concerning the importance of the non-neuronal cholinergic signaling cascades. This suggests that the activation of ACh receptors is involved in cardioprotection against myocardial I/R injury. There are two types of ACh receptors (AChRs), namely muscarinic and nicotinic receptors (mAChRs and nAChRs, respectively). However, the effects of AChRs activation in cardioprotection during myocardial I/R are still not fully understood. In this review, we summarize the evidence suggesting the association between AChRs activation with both electrical and pharmacological interventions and the cardioprotection during myocardial I/R, as well as outline potential mechanisms underlying these cardioprotective effects.
No takes yet. Share an insight, caveat, or question.
Intachai et al. (2018) conducted a review in Myocardial ischemia/reperfusion (I/R) injury. Acetylcholine receptor (AChR) activation was evaluated on Cardioprotection against myocardial ischemia/reperfusion injury. Activation of acetylcholine receptors through electrical and pharmacological interventions is associated with cardioprotective effects against myocardial ischemia/reperfusion injury.
Synapse has enriched 10 related papers. Consider them for comparative context: